0001140361-24-017566.txt : 20240403 0001140361-24-017566.hdr.sgml : 20240403 20240403160148 ACCESSION NUMBER: 0001140361-24-017566 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240401 FILED AS OF DATE: 20240403 DATE AS OF CHANGE: 20240403 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: USMAN NASSIM CENTRAL INDEX KEY: 0001206872 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51173 FILM NUMBER: 24818599 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GYRE THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001124105 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 562020050 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12770 HIGH BLUFF DRIVE, SUITE 150 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (619) 949-3681 MAIL ADDRESS: STREET 1: 12770 HIGH BLUFF DRIVE, SUITE 150 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: CATALYST BIOSCIENCES, INC. DATE OF NAME CHANGE: 20150820 FORMER COMPANY: FORMER CONFORMED NAME: TARGACEPT INC DATE OF NAME CHANGE: 20000919 4 1 form4.xml FORM 4 X0508 4 2024-04-01 0001124105 GYRE THERAPEUTICS, INC. GYRE 0001206872 USMAN NASSIM C/O GYRE THERAPEUTICS, INC. 12770 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130 true true Common Stock 2024-04-01 4 M 0 20000 6.93 A 21636 D Common Stock 2024-04-01 4 S 0 20000 16.15 D 1636 D Common Stock 563 I By The Usman Family Trust Common Stock 77 I By Nassim Usman IRA Stock Option (Right to Buy) 6.93 2024-04-01 4 M 0 20000 0 D 2033-10-31 Common Stock 20000 301652 D This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on December 12, 2023. The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $15.80 to $17.15. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. This option is vested in full. /s/ Ruoyu Chen, as attorney-in-fact for Nassim Usman 2024-04-03